1. Home
  2. RUN vs NVAX Comparison

RUN vs NVAX Comparison

Compare RUN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$6.94

Market Cap

2.1B

Sector

Miscellaneous

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$10.85

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
NVAX
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
RUN
NVAX
Price
$6.94
$10.85
Analyst Decision
Buy
Buy
Analyst Count
20
9
Target Price
★ $14.64
$14.22
AVG Volume (30 Days)
7.4M
★ 8.0M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
113.35
★ 309.76
EPS
★ 1.04
N/A
Revenue
$858,578,000.00
★ $1,123,479,000.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$3.38
N/A
P/E Ratio
$7.01
★ N/A
Revenue Growth
12.97
★ 64.69
52 Week Low
$7.17
$6.20
52 Week High
$21.95
$13.39

Technical Indicators

Market Signals
Indicator
RUN
NVAX
Relative Strength Index (RSI) 33.27 47.76
Support Level N/A $7.93
Resistance Level $8.95 $11.73
Average True Range (ATR) 0.34 1.17
MACD -0.00 -0.09
Stochastic Oscillator 2.39 18.01

Price Performance

Historical Comparison
RUN
NVAX

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: